Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Aryl-urea fatty acids that activate the p38 MAP kinase and down-regulate multiple cyclins decrease the viability of MDA-MB-231 breast cancer cells.

Al-Zubaidi Y, Pazderka C, Koolaji N, Rahman MK, Choucair H, Umashankar B, Bourget K, Chen Y, Rawling T, Murray M.

Eur J Pharm Sci. 2019 Mar 1;129:87-98. doi: 10.1016/j.ejps.2018.12.015. Epub 2018 Dec 29.

PMID:
30597206
2.

Nanoemulsion-Enabled Oral Delivery of Novel Anticancer ω-3 Fatty Acid Derivatives.

Garrastazu Pereira G, Rawling T, Pozzoli M, Pazderka C, Chen Y, Dunstan CR, Murray M, Sonvico F.

Nanomaterials (Basel). 2018 Oct 13;8(10). pii: E825. doi: 10.3390/nano8100825.

3.

Omega-3 Polyunsaturated Fatty Acid Derived Lipid Mediators and Their Application in Drug Discovery.

Pazderka CW, Oliver B, Murray M, Rawling T.

Curr Med Chem. 2018 Sep 26. doi: 10.2174/0929867325666180927100120. [Epub ahead of print]

PMID:
30259807
4.

Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs.

Murray M, Hraiki A, Bebawy M, Pazderka C, Rawling T.

Pharmacol Ther. 2015 Jun;150:109-28. doi: 10.1016/j.pharmthera.2015.01.008. Epub 2015 Jan 17. Review.

PMID:
25603423

Supplemental Content

Loading ...
Support Center